Neuralink — the brain implant startup founded by Elon Musk — is moving forward with plans to commence human trials after receiving approval from the Food and Drug Administration (FDA) in May. The company is actively recruiting participants, specifically seeking individuals with caregivers and those who have quadriplegia or spinal cord injuries. Yahoo Finance's Anjalee Khemlani breaks down the qualifications and terms of eligibility for participating in the testing trials. For more expert insight and the latest market action, click here to watch this full episode of Yahoo Finance Live.
Subscribe to Yahoo Finance: https://yhoo.it/2fGu5Bb
#ElonMusk #yahoofinance #youtube

About Yahoo Finance:
At Yahoo Finance, you get free stock quotes, up-to-date news, portfolio management resources, international market data, social interaction and mortgage rates that help you manage your financial life.

Yahoo Finance Plus: With a subscription to Yahoo Finance Plus get the tools you need to invest with confidence. Discover new opportunities with expert research and investment ideas backed by technical and fundamental analysis. Optimize your trades with advanced portfolio insights, fundamental analysis, enhanced charting, and more.
To learn more about Yahoo Finance Plus please visit: https://yhoo.it/33jXYBp

Connect with Yahoo Finance:
Get the latest news: https://yhoo.it/2fGu5Bb
Find Yahoo Finance on Facebook: http://bit.ly/2A9u5Zq
Follow Yahoo Finance on Twitter: http://bit.ly/2LMgloP
Follow Yahoo Finance on Instagram: http://bit.ly/2LOpNYz
Follow Yahoo Finance Premium on Twitter: https://bit.ly/3hhcnmV